MYX 0.46% $4.38 mayne pharma group limited

Ann: 2024 Half Year Investor Presentation, page-138

  1. 1,372 Posts.
    lightbulb Created with Sketch. 263
    As long as we can maintain or preferably
    grow revenue and decrease o/ heads.
    Basically we need to be nett cash positive
    and profitable. Because should this not be
    the case and we’re cash poor then any
    thing goes wrong in any area. Sales, unexpected
    problem, any little negativity in politics to effect
    us and we have zero real credibility financially
    to call upon.
    May well turn out for the better but still RISKY!
    To some degree a gamble. Nothing worse than
    taking on more than you can chew under
    capitalised !!. Just the same the CEO appears
    to be doing everything right so far as I can see.
    My only question is if all is as it appears why oh
    ehy haven’t the Directors splashed their cash to
    give more clarity to our apparent growth projections.?
 
watchlist Created with Sketch. Add MYX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.